These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8855869)

  • 21. [P-pills, hormonal substitution and surgery--yes, or no?].
    Maltau JM; Oian P
    Tidsskr Nor Laegeforen; 1995 Mar; 115(8):934. PubMed ID: 7709380
    [No Abstract]   [Full Text] [Related]  

  • 22. [Postmenopausal hormonal substitution and risk of venous thromboembolism. Need for prospective, randomized trials].
    Arnesen H; Qvigstad E
    Tidsskr Nor Laegeforen; 1997 Nov; 117(28):4064. PubMed ID: 9441436
    [No Abstract]   [Full Text] [Related]  

  • 23. Hormone replacement therapy is not a risk for venous thrombosis.
    Forbes CD; Greer IA
    Scott Med J; 1994 Dec; 39(6):165-6. PubMed ID: 8778977
    [No Abstract]   [Full Text] [Related]  

  • 24. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
    Canonico M; Fournier A; Carcaillon L; Olié V; Plu-Bureau G; Oger E; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Scarabin PY
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):340-5. PubMed ID: 19834106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
    Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M
    Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
    Brinton LA; Hoover RN
    Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex steroid hormones and breast cancer: is there a link with oral contraceptives and hormone replacement therapy?
    Khoo SK; Chick P
    Med J Aust; 1992 Jan; 156(2):124-32. PubMed ID: 1736053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogens, oral contraceptives and hormonal replacement therapy increase the incidence of cutaneous melanoma: a population-based case-control study.
    Koomen ER; Joosse A; Herings RM; Casparie MK; Guchelaar HJ; Nijsten T
    Ann Oncol; 2009 Feb; 20(2):358-64. PubMed ID: 18725391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen replacement therapy and the risk of venous thrombosis.
    Devor M; Barrett-Connor E; Renvall M; Feigal D; Ramsdell J
    Am J Med; 1992 Mar; 92(3):275-82. PubMed ID: 1546726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bilateral Paget-v-Schrötter syndrome. Hormonal contraception and the risk of thrombosis--a case report (author's transl)].
    Tamm D; Uhlenbruch K; Maass D
    Dtsch Med Wochenschr; 1974 Apr; 99(16):836-8. PubMed ID: 4828660
    [No Abstract]   [Full Text] [Related]  

  • 31. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K; Oger E
    Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menopause, postmenopausal estrogen preparations, and the risk of adult-onset asthma. A prospective cohort study.
    Troisi RJ; Speizer FE; Willett WC; Trichopoulos D; Rosner B
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1183-8. PubMed ID: 7551368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Vascular disorders and synthetic estroprogestatives].
    Servelle M; Babilliot J
    Phlebologie; 1972; 25(3):259-61. PubMed ID: 4662051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Peroral contraceptives and thromboembolism].
    Asperger Z
    Lijec Vjesn; 1969 Jul; 91(7):779-82. PubMed ID: 4910828
    [No Abstract]   [Full Text] [Related]  

  • 35. Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women.
    Olié V; Canonico M; Scarabin PY
    Curr Opin Hematol; 2010 Sep; 17(5):457-63. PubMed ID: 20601871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral contraceptives, pregnancy, and the veins.
    Wood JE
    Circulation; 1968 Oct; 38(4):627-8. PubMed ID: 5677948
    [No Abstract]   [Full Text] [Related]  

  • 37. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
    Bounameaux H; de Moerloose P; Campana A
    Schweiz Med Wochenschr; 1996 Oct; 126(41):1756-63. PubMed ID: 8966508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
    Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
    N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone therapy and recurrence of venous thromboembolism among postmenopausal women.
    Olié V; Plu-Bureau G; Conard J; Horellou MH; Canonico M; Scarabin PY
    Menopause; 2011 May; 18(5):488-93. PubMed ID: 21178641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy.
    Douketis JD; Ginsberg JS; Holbrook A; Crowther M; Duku EK; Burrows RF
    Arch Intern Med; 1997 Jul; 157(14):1522-30. PubMed ID: 9236553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.